Right Care Action Week: October 15-21

The Lown Institute’s Right Care Alliance (RCA) is revving up across the country for Right Care Action Week (October 15-21). For the third consecutive year, healthcare practitioners and ‘consumers’ alike will ask people ‘What worries you most about healthcare?’ — with this year’s focus being on what drives up health care costs.

Some cost pushers . . . → Read More: Right Care Action Week: October 15-21

Book Review: Hospital Land USA

Death is certain. Time of death is not. But in Hospital Land USA, the other S&M (Science and Medicine) as Wendy Simonds calls it, death is a failure, something to be suspended and avoided at whatever cost. And there is no safe word. The surreal ordinariness of it all – from appointments and forms to . . . → Read More: Book Review: Hospital Land USA

Update on Lown Institute's Right Care Action Week

The Lown Institute’s Right Care Alliance is building a grassroots social movement to fix healthcare by reaching out to the public and healthcare practitioners. The mission is basic and profound:

Profit-driven overuse, under-use, and misuse of medical tests and treatments have subverted the work of health care providers. A much better health care system is . . . → Read More: Update on Lown Institute’s Right Care Action Week

What Worries You Most About Health Care?

The Lown Institute is a nonprofit, action-driven think tank founded by cardiologist and Nobel Peace Prize recipient, Bernard Lown, MD. Dedicated to transforming the culture of medicine and building a healthcare system that is affordable, effective, personal and just, the Institute created the RightCare Alliance to bring health professionals, religious and community groups, and the . . . → Read More: What Worries You Most About Health Care?

The Lown Institute's RightCare Alliance

The Lown Institute’s RightCare Alliance is a grassroots movement of clinicians, patients, and community leaders who are demanding and creating change to the healthcare industry — one that sees patients as people, not profits, and gives everyone access not just to care but to the RIGHT CARE for their medical needs.

Learn more: www.rightcarealliance.org . . . → Read More: The Lown Institute’s RightCare Alliance

How Should We Address Breast Cancer When Norms Continually Change?

Accompanying Photograph: Andy Katz/Demotix/Corbis

When faced with decisions about breast cancer treatment or screening, it can be hard to know what to think.

Gayle Sulik, The Guardian, Oct. 20, 2015

Three decades ago, researchers believed breast cancer was one disease, so it made sense to treat it that . . . → Read More: How Should We Address Breast Cancer When Norms Continually Change?

Effective Ovarian Cancer Treatment Is Underused, Study Finds

“Effective Ovarian Cancer Treatment Is Underused, Study Finds,” by Denise Grady, The New York Times.

In 2006, the National Cancer Institute took the rare step of issuing a “clinical announcement,” a special alert it holds in reserve for advances so important that they should change medical practice. In this case, the . . . → Read More: Effective Ovarian Cancer Treatment Is Underused, Study Finds

The Importance of Getting Sick in the Right Place

“The Importance of Getting Sick in the Right Place” by Abigail Zuger MD, The New York Times.

It is increasingly critical for patients to be sick in the right place, and increasingly difficult for them to do so. As the great plates of medical care heave and split in cash-based tectonics, the options are multiplying . . . → Read More: The Importance of Getting Sick in the Right Place

Marketing to Doctors

“Marketing to Doctors,” John Oliver, Last Week Tonight with John Oliver.

This eye-opening video reveals how pharmaceutical companies spend billions of dollars every year marketing drugs to you and your doctors.

A study in 2013 found that 9 out of 10 of the top ten drug manufacturers spent more on marketing than they did . . . → Read More: Marketing to Doctors

Why Drugs Cost So Much

“Why Drugs Cost So Much,” Peter Bach, The New York Times.

ELI LILLY charges more than $13,000 a month for Cyramza, the newest drug to treat stomach cancer. The latest medicine for lung cancer, Novartis’s Zykadia, costs almost $14,000 a month. Amgen’s Blincyto, for leukemia, will cost $64,000 a month. Cyramza costs the average . . . → Read More: Why Drugs Cost So Much

Articles & Posts